Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

β-defensin 22 Inhibitors

β-defensin 22 inhibitors represent a unique class of molecules that interact with β-defensin 22, a member of the defensin family of antimicrobial peptides. Defensins are small, cysteine-rich proteins found in a variety of organisms, ranging from humans to insects. Structurally, β-defensin 22 exhibits a conserved disulfide-linked structure that stabilizes its three-dimensional conformation. Inhibitors of β-defensin 22 are typically designed or identified to bind specifically to this peptide, disrupting its natural structural integrity or modulating its ability to interact with other biological components. These inhibitors may target key regions within the β-defensin 22 peptide, such as its positively charged surface or the cysteine-stabilized loops, leading to alterations in its molecular function. The inhibitors can be small organic molecules, peptides, or even larger protein-based inhibitors, all designed to interact with the precise folding patterns and binding sites of β-defensin 22.

Research into β-defensin 22 inhibitors delves into the structural dynamics of both the inhibitor and the target peptide. These studies often involve advanced biophysical techniques like nuclear magnetic resonance (NMR), X-ray crystallography, and molecular modeling to understand the binding affinities, conformational changes, and mechanistic details of inhibition. Computational docking studies and molecular dynamics simulations play an integral role in predicting how various inhibitors may interact with β-defensin 22 at the atomic level. This helps researchers elucidate the key binding interactions and optimize inhibitor design. Moreover, the development of these inhibitors often requires an understanding of the chemical environment in which β-defensin 22 operates, including its interaction with membranes, ions, and other proteins. Consequently, β-defensin 22 inhibitors are a focal point for understanding molecular interactions and biochemical pathways, making them a valuable subject of biochemical research.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PI 3-Kγ Inhibitor

648450-29-7sc-203191
5 mg
$76.00
(0)

PI3Kγ inhibitor influencing β-defensin 22 through the PI3K/Akt pathway. AS605240 inhibits PI3Kγ, disrupting downstream signaling events. This interference leads to the downregulation of β-defensin 22 at the transcriptional level in response to extracellular stimuli.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

IKK inhibitor affecting β-defensin 22 indirectly through NF-κB pathway. BAY 11-7082 inhibits IKK, preventing IκB degradation and NF-κB activation. This disruption leads to downregulated β-defensin 22 expression by impeding the transcriptional regulation events.